Clinical trial
Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment…
NCT00372125 · Karolinska University Hospital, Other · Completed
Key facts
| NCT number | NCT00372125 |
|---|---|
| Title | Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome |
| Official title | Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome |
| Lead sponsor | Karolinska University Hospital, Other |
| Collaborators | Novo Nordisk A/S Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prader-Willi Syndrome |
| Intervention type | Drug |
| Interventions | Norditropin SimpleXx |
| Enrollment | 46 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 6, 2006 |
| Last update posted | Sep 13, 2016 |
| Countries | Denmark, Norway, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: